Skip to main content

Table 2 Serum lipids and lipoproteins (mmol/l) during the study.

From: Short-term LDL cholesterol-lowering efficacy of plant stanol esters

 

Experimental period

Follow-up period

  
 

0 day

4 days

8 days

15 days

17 or 18 days

22 days

P1

P2

Total cholesterol

6.33 ± 0.64

6.16 ± 0.74

5.81 ± 0.76a

6.06 ± 0.83

6.16 ± 0.75

6.30 ± 0.87

0.014

0.316

LDL cholesterol

4.51 ± 0.66

4.34 ± 0.69

4.06 ± 0.75a

4.04 ± 0.68a

4.21 ± 0.67

4.26 ± 0.72

0.001

0.183

HDL cholesterol

1.36 ± 0.31

1.34 ± 0.31

1.31 ± 0.30

1.36 ± 0.30

1.35 ± 0.34

1.37 ± 0.35

0.247

0.935

VLDL cholesterol

0.47 ± 0.26

0.48 ± 0.22

0.44 ± 0.27

0.67 ± 0.21a

0.60 ± 0.18

0.66 ± 0.54

0.011

0.811

Triglycerides

1.61 ± 0.54

1.41 ± 0.55

1.40 ± 0.57

1.61 ± 0.59

1.47 ± 0.46

1.90 ± 1.04

0.311

0.236

  1. Values are means ± SD, n = 11. 1 indicate the significance of the differences for overall changes during the experimental period (days 0–15) analyzed with analysis of variance for repeated measurements (MANOVA). 2 indicate the significance of the differences for overall changes during the follow-up period (days 15–22) analyzed with analysis of variance for repeated measurements (MANOVA). a p < 0.05 significantly different from the values of 0 day analyzed with paired t-test with Bonferroni correction.
  2. Footnotes. During the experimental period the percentage changes (versus 0 day) in serum total cholesterol were -2.6 ± 8.1%, -8.2 ± 8.7% and -4.3 ± 8.1% at days 4, 8 and 15, respectively, and during the follow up period the changes were -2.7 ± 7.2% and -0.6 ± 8.8% at days 17/18 and 22, respectively. Respective changes in serum LDL cholesterol were -3.5 ± 8.9%, -9.9 ± 10.4%, -10.2 ± 10.5%, -6.5 ± 8.7% and -5.3 ± 10.0%.